Nevro
Recent Finacing
Series C
Recent Raise
$48M
Nevro develops and commercializes high-frequency spinal cord stimulation devices, including the Senza HF10 delivering up to 10 kHz for chronic pain, commercially available outside the U.S. and in U.S. trials.
Highlights
Focus Areas
Biotechnology
Health Care
Health Diagnostics
Manufacturing
Pharmaceutical
Recent Investors
Financials
$106M
Total Raised
2
Funding rounds
10
Investors